Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2022-08-11 Purchase | 2022-08-15 5:49 pm | Protara Therapeutics Inc. | TARA | Shefferman Jesse CEO and President | 9,065 | $3.84 | $34,810 | 879,441 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2024-08-28 Gift | 2024-08-30 4:05 pm | N/A N/A | Protara Therapeutics Inc. | TARA | Shefferman Jesse CEO and President | 8,563 | $0 | 935,501 (Direct) | View |
2024-01-19 Option Award | 2024-01-23 4:05 pm | N/A 2034-01-18 | Protara Therapeutics Inc. | TARA | Shefferman Jesse CEO and President | 416,000 | $0 | 1,301,064 (Direct) | View |
2024-01-19 Tax Withholding | 2024-01-23 4:05 pm | N/A N/A | Protara Therapeutics Inc. | TARA | Shefferman Jesse CEO and President | 7,803 | $1.91 | 1,301,064 (Direct) | View |
2024-01-10 Tax Withholding | 2024-01-12 4:05 pm | N/A N/A | Protara Therapeutics Inc. | TARA | Shefferman Jesse CEO and President | 5,746 | $2.39 | 892,867 (Direct) | View |
2024-01-03 Tax Withholding | 2024-01-05 4:30 pm | N/A N/A | Protara Therapeutics Inc. | TARA | Shefferman Jesse CEO and President | 5,840 | $2.17 | 898,613 (Direct) | View |
2023-06-23 Gift | 2023-06-27 7:26 pm | N/A N/A | Protara Therapeutics Inc. | TARA | Shefferman Jesse CEO and President | 9,310 | $0 | 904,453 (Direct) | View |
2022-06-27 Ownership | 2023-02-10 4:05 pm | N/A N/A | Protara Therapeutics Inc. | TARA | Shefferman Jesse CEO and President | 4,519 | $0 | 913,763 (Direct) | View |
2023-01-19 Option Award | 2023-01-20 4:00 pm | N/A 2033-01-18 | Protara Therapeutics Inc. | TARA | Shefferman Jesse CEO and President | 358,800 | $0 | 1,225,782 (Direct) | View |
2023-01-10 Tax Withholding | 2023-01-11 4:03 pm | N/A N/A | Protara Therapeutics Inc. | TARA | Shefferman Jesse CEO and President | 5,855 | $3 | 866,982 (Direct) | View |
2023-01-03 Tax Withholding | 2023-01-04 4:25 pm | N/A N/A | Protara Therapeutics Inc. | TARA | Shefferman Jesse CEO and President | 6,604 | $2.8 | 872,837 (Direct) | View |
2021-06-29 Ownership | 2022-02-11 4:49 pm | N/A N/A | Protara Therapeutics Inc. | TARA | Shefferman Jesse CEO and President | 2,049 | $0 | 870,376 (Direct) | View |
2022-01-10 Tax Withholding | 2022-01-12 5:18 pm | N/A N/A | Protara Therapeutics Inc. | TARA | Shefferman Jesse CEO and President | 5,080 | $6.27 | 872,425 (Direct) | View |
2022-01-03 Option Award | 2022-01-05 4:36 pm | N/A 2032-01-02 | Protara Therapeutics Inc. | TARA | Shefferman Jesse CEO and President | 295,800 | $0 | 1,131,005 (Direct) | View |
2021-01-19 Option Award | 2021-01-21 3:03 pm | N/A 2031-01-18 | Protara Therapeutics Inc. | TARA | Shefferman Jesse CEO and President | 202,000 | $0 | 202,000 (Direct) | View |
2021-01-11 Tax Withholding | 2021-01-13 5:16 pm | N/A N/A | Protara Therapeutics Inc. | TARA | Shefferman Jesse CEO and President | 5,069 | $21.16 | 835,205 (Direct) | View |
2020-07-10 Option Award | 2020-07-13 2:56 pm | N/A 2030-07-09 | Protara Therapeutics Inc. | TARA | Shefferman Jesse CEO and President | 111,250 | $0 | 111,250 (Direct) | View |
2020-01-10 Option Award(A) | 2020-02-18 4:30 pm | N/A 2030-01-09 | ArTara Therapeutics Inc. | TARA | Shefferman Jesse CEO and President | 111,250 | $0 | 111,250 (Direct) | View |
2020-01-10 Option Award | 2020-01-13 6:57 pm | N/A 2030-01-09 | ArTara Therapeutics Inc. | TARA | Shefferman Jesse CEO and President | 951,524 | $0 | 951,524 (Direct) | View |